Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Psychiatry
•
Neuromodulation
•
Major Depressive Disorder
•
Anxiety Disorders
•
General Psychiatry
What is your experience with transcutaneous vagal nerve stimulation for the treatment of anxiety disorders and major depressive disorder?
Answer from: at Community Practice
Just starting to recommend, have had a few folks with side effects and unclear results. A colleague noted about a 30-40% response rate.
Sign in or Register to read more
27301
Related Questions
What are your considerations when treating insomnia in perimenopausal patients with comorbid anxiety or mood disorders?
How do you approach treatment-resistant depression and anxiety related to menopause refractory to SSRI/SNRIs and hormone replacement therapy?
What strategies have you found helpful to manage SSRI associated night sweats?
How do you use TMS for tinnitus? Where do you target, and what settings on the magnet do you use? Is anyone using either iTBS or cTBS for this!?
Would you use bupropion for mood disorder or substance use in an adult patient with previous childhood seizures that resolved?
How do you approach tapering electroconvulsive therapy after an acute treatment course leading to successful resolution of symptoms for treatment-resistant depression?
What criteria do you use when deciding whether to start esketamine treatment for patients with treatment resistant MDD who are concomitant CNS depressants?
Do you believe that buspirone is ineffective in patients who are previously treated with benzodiazepines?
How do you evaluate patients who report medications frequently "stop working" after long periods of stability?
How do you determine the treatment course of esketamine or IV ketamine when used for treatment-resistant major depressive disorder?